Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Theralase Technologies Inc. V.TLT

Alternate Symbol(s):  TLTFF

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.


TSXV:TLT - Post by User

Post by Eoganachton Jan 23, 2024 11:56am
391 Views
Post# 35840989

Is a 25% No Response rate inevitable ?

Is a 25% No Response rate inevitable ?Our current trial results are excellent and should get us BTD, hopefully AA, and eventually full approval. Our interim results show a total response at any time of 75% (64% CR + 10% IR)

But why do 25% of patients show no response to the treatment? There must be a reason. Could different patients require a slightly different dose of light or photosensitizer? With some patients could there be cancer cells hidden under the surface or behind a stubborn tissue fold that either the photosensitizer or green light did not reach? Could the judicious use of deeper-penetrating red light along with green light help improve results in some cases?

Now is probably not the right time, but after approval, when Theralase has the money for more research and optimizations might it not be possible to whittle that 25% down so that a higher percentage of patients are completely cured of their disease?
<< Previous
Bullboard Posts
Next >>